Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01098292 · ClinicalTrials.gov registry record
Observational Study of Control Participants for the MAPP Research Network
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 615
- Enrollment target
NCT01098292: Completed study, sponsored by University of Pennsylvania.
NCT01098292 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 615 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01098292 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 615 participants
- Enrollment target
Study Summary
The Control Study for the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network has been established to focus on a broader approach to the study of Interstitial Cystitis (IC)/Painful Bladder Syndrome (PBS) in men and women, and Chronic Prostatitis (CP)/Chronic Pelvic Pain Syndrome (CPPS) in men, than previously undertaken. Participants with no Urologic Pelvic Pain Syndromes as well as participants with specific conditions (Fibromyalgia (FM), Irritable Bowel Syndrome (IBS), Chronic Fatigue Syndrome (CFS)) are being recruited for the Trans-MAPP Control Study. These participants will act as a reference/control group for the Trans-MAPP Epidemiology \& Phenotyping (EP) Study. As with many chronic pain disorders, IC and CP are poorly understood, and treatment is often not helpful. The goal of this study is to better understand how pain is felt in people with IC or CP. The MAPP Control Study is an observational study that will enroll participants from 6 Discovery Sites and 3 Satellite Sites across the U.S. The investigators will ask questions and gather information about the health and life of the participants for research purposes. The investigators hope that this study will lead to improvement in the treatment of IC and CP.
Primary Outcome
Extensive data on risk factors and outcomes measures will be collected for the Trans-MAPP Control Study. These measures can be classified into a number of primary domains as described below. 1. General Measures of Sociodemographics, Health, and Quality of Life 2. UCPPS Symptoms Measures 3. Non-urological Symptom Measures 4. Trait-like Personal Factors 5. Biological Specimens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 615 participants |
| Start Date | 2009-12 |
| Est. Completion | 2014-06 |
What the finished NCT01098292 record still lists
NCT01098292 is an observational study that tracks outcomes without assigning an intervention. The registered 615 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01098292 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01098292 about?
NCT01098292 is a clinical study titled "Observational Study of Control Participants for the MAPP Research Network". The Control Study for the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network has been established to focus on a broader approach to the study of Interstitial Cystitis (IC)/Painful Bladder Syndrome (PBS) in men and women, and Chronic Prostatitis (CP)/Chronic Pelvic...
What is the current status of trial NCT01098292?
This trial is currently completed. The enrollment target is 615 participants. The study started on 2009-12. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01098292?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06593652 · 615 participants · NA
Evaluating Caregiver Involvement in Primary Care-Based Brief Interventions for Adolescent Alcohol Use Problems
- NCT04813185 · 616 participants · NA
Preventing Retaliatory Gun Violence in Violently Injured Adults
- NCT06105957 · 616 participants · NA
Optimal Digital Weight Loss Treatment for Rural Individuals
- NCT06162221 · 616 participants · Phase 1
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia